Compound sulfamethoxazole granules
Indication
In recent years, many common clinical pathogens are often resistant to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. Treatment of Pneumocystis carinii pneumonia,
Precautions
1. This product is contraindicated for children under 2 months old; 2. This product is contraindicated for those who are allergic to SMZ and TMP; 3. This product is contraindicated for patients with megaloblastic anemia because it blocks the metabolism of folic acid and aggravates the folate deficiency in patients with this disease; 4. This product is contraindicated for those with severe liver and kidney damage.
Special Population Medication
Precautions for children: This product is contraindicated for children under 2 months old. Precautions for pregnancy and lactation: Use with caution for pregnant women and not for lactating women. Precautions for the elderly: Use with caution for the elderly.
Packaging Specification
Sulfadimethoxazole 0.8g, trimethoprim 0.16g
Manufacturer
Suzhou Yifan Pharmaceutical Co., Ltd.
-
Founded in:
2013-03-21 -
Address:
North side of Jinjiang Road, Suzhou Economic Development Zone, Anhui Province -
Tax NO.:
91341300065208048B -
Registered Funds:
250 million yuan -
Email: